List of news
-
Category: UCLH news
Published on: 24 November 2025
On Sunday 23 November, the Royal National Orthopaedic Hospital (RNOH) successfully connected to UCLH’s Epic electronic health record (EHR). This is another milestone in our collaboration and digital transformation across North Central London.
-
Category: UCLH news
Published on: 21 November 2025
UCLH has welcomed its 1000th patient to our proton beam therapy department, which opened in December 2021.
-
Category: Research news
Published on: 10 November 2025
The Queen Square Clinical Trial Centre (QSCTC) has successfully delivered its first investigational medicinal product (IMP) treatment on John Young Ward at the National Hospital for Neurology and Neurosurgery.
-
Category: UCLH news
Published on: 10 November 2025
There is industrial action by resident doctors (formerly known as junior doctors) from 7am on Friday 14 November until 7am on Wednesday 19 November
-
Category: UCLH news
Published on: 05 November 2025
UCLH has been confirmed as a key partner in the development of neighbourhood health services in north central London.
-
Category: Charity news
Published on: 03 November 2025
Today we are launching our Gift of Giving appeal, bringing cheer to UCLH this festive season.
-
Category: UCLH news
Published on: 31 October 2025
-
Category: Research news
Published on: 30 October 2025
UCLH has recruited the first participant in the UK for a study testing a new anti-cancer treatment combination for advanced solid tumours such as endometrial and ovarian cancers.
-
Category: UCLH news
Published on: 27 October 2025
A patient with motor neurone disease was able to control a computer just by using his thoughts following the UK’s first Neuralink implant surgery at UCLH’s National Hospital for Neurology and Neurosurgery (NHNN) in October 2025.
-
Category: UCLH news
Published on: 24 October 2025
A multiple sclerosis (MS) patient in the UK is the first to receive CAR T cell therapy in a UCLH clinical trial testing whether this personalised treatment may slow or even halt the progression of the disease.
